Test filters

News

In the media

Press releases

Publications

Scientific articles

Statements

Stories

Videos

Viewpoints

Press releases

13 Jul 2026

DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security

Press releases

13 Jul 2026

DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals

Press Releases Translations

8 Jul 2026

Brasil, Malásia e Tailândia estão prestes a iniciar ensaio clínico para testar tratamento promissor contra a dengue desenvolvido pelo Instituto Serum da Índia

Press Releases Translations

8 Jul 2026

Brasil, Malasia y Tailandia están a punto de iniciar ensayos clínicos para probar un prometedor tratamiento contra el dengue desarrollado por el Serum Institute of India

Press releases

8 Jul 2026

Brazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment developed by Serum Institute of India

Press Releases Translations

8 Jul 2026

ไทย บราซิล และ มาเลเซีย เตรียมเริ่มการศึกษาวิจัยทางคลินิก เพื่อทดสอบยารักษาไข้เลือดออกชนิดใหม่ที่พัฒนาโดยสถาบันเซรุ่มแห่งอินเดีย

Stories

30 Jun 2026

Cryptococcal meningitis: Africa’s neglected HIV killer

Publications

30 Jun 2026

2025 DNDi Financial Report

Publications

29 Jun 2026

Advancing global health innovation through Europe-Africa collaboration

News

29 Jun 2026

Eric Easom, Dr Marcus Lacerda, and Mathieu Lamiaux join the DNDi Board of Directors

Scientific articles

22 Jun 2026

What Is in a Structure? Cell Permeability and Solubility of Series of Macrocycles and Linear Matched Pairs

Journal of Medicinal Chemistry

Scientific articles

17 Jun 2026

Advancing diagnostics for Chagas disease: key product characteristics and harmonized evaluation strategies – an expert meeting report

BMC Infectious Diseases

News

17 Jun 2026

DNDi and Medicines for Malaria Venture (MMV) pool regulatory expertise to accelerate access to lifesaving medicines

Stories

17 Jun 2026

The DNDi-MMV Joint Regulatory Platform: ‘a pioneering programme project for non-profit medical research organizations to speak with one voice’

Press Releases Translations

12 Jun 2026

La RDC approuve l’utilisation de l’acoziborole, un traitement oral à dose unique contre la maladie du sommeil

Press releases

12 Jun 2026

DRC approves the use of acoziborole, a breakthrough one-day oral treatment against sleeping sickness

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security

DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals

Brasil, Malásia e Tailândia estão prestes a iniciar ensaio clínico para testar tratamento promissor contra a dengue desenvolvido pelo Instituto Serum da Índia

Brasil, Malasia y Tailandia están a punto de iniciar ensayos clínicos para probar un prometedor tratamiento contra el dengue desarrollado por el Serum Institute of India

Brazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment developed by Serum Institute of India

Cryptococcal meningitis: Africa’s neglected HIV killer

2025 DNDi Financial Report

Advancing global health innovation through Europe-Africa collaboration

Eric Easom, Dr Marcus Lacerda, and Mathieu Lamiaux join the DNDi Board of Directors

What Is in a Structure? Cell Permeability and Solubility of Series of Macrocycles and Linear Matched Pairs

Advancing diagnostics for Chagas disease: key product characteristics and harmonized evaluation strategies – an expert meeting report

DNDi and Medicines for Malaria Venture (MMV) pool regulatory expertise to accelerate access to lifesaving medicines

The DNDi-MMV Joint Regulatory Platform: ‘a pioneering programme project for non-profit medical research organizations to speak with one voice’

La RDC approuve l’utilisation de l’acoziborole, un traitement oral à dose unique contre la maladie du sommeil

DRC approves the use of acoziborole, a breakthrough one-day oral treatment against sleeping sickness

Learn more

Get in touch

Support us

Work with us